PERSPECTA

News from every angle

Back to headlines

Jim Cramer Criticizes ImmunityBio Stock as 'Magical Thinking Era'

Financial commentator Jim Cramer has expressed skepticism about ImmunityBio, stating that its stock is indicative of a 'magical thinking era' in the market.

21 Mar, 16:31 — 21 Mar, 16:31
PostShare

Sources

Showing 1 of 1 sources